Biomarkers · Chemical
ALT
An ALT test measures the amount of ALT in your blood. This test is commonly used to help diagnose liver damage or disease.
- Also listed as
- alanine transaminase, alanine aminotransferase, sgpt, ALT P5P
- Primary unit
- IU/L
- LOINC codes
- 1743-4, 1742-6
- Tests that measure ALT
- Labcorp 24, Quest Diagnostics 19
Ranges
Compare the reference ranges labs publish with guideline targets, diagnostic cut-offs, study-based ranges and practitioner targets. Move across the rows to check a value against each range, and open a source from the legend. How to read these ranges
ALT, U/L
- Lab reference ranges1 lab
- Diagnostic cut-offs2 cut-offs
All 4 published ranges, with sources
Lab reference ranges
Quest, men 20 and older9 to 46 U/L
Men 20 and older
Quest Diagnostics Test Directory, Alanine Aminotransferase (ALT) (823), 2025
Quest, women 20 and older6 to 29 U/L
Women 20 and older
Quest Diagnostics Test Directory, Alanine Aminotransferase (ALT) (823), 2025
Diagnostic cut-offs
ACG 2017 true healthy upper limit, menbelow 33 U/L
Men
A true healthy normal ALT ranges from 29 to 33 IU/L in men.
ACG 2017 true healthy upper limit, womenbelow 25 U/L
Women
A true healthy normal ALT ranges from 19 to 25 IU/L in women.
Tests
Check the catalog code, specimen, method and preparation for every test that measures ALT. Select up to five tests to compare them side by side.
Labcorp 24 tests
Single-analyte tests
Alanine Aminotransferase (ALT/SGPT) 001545
Serum · Fasting not stated · Turnaround Within 1 day
Labcorp catalog pageMethod and collection
- Method
- Kinetic
- Collection
- Separate serum or plasma from cells within 45 minutes of collection.
Panels that include this biomarker
Drug-Induced Liver Injury Pattern Assessment with Calculation of R Value 010035
2 analytes · Serum · Fasting not stated · Turnaround Within 1 day
Labcorp catalog pageMethod and collection
- Method
- See individual tests.
- Collection
- Separate serum or plasma from cells within 45 minutes of collection.
FIB-4 403604
4 analytes · Serum · Fasting not stated · Turnaround Within 1 day
Labcorp catalog pageMethod and collection
- Method
- AST and ALT: Kinetic Platelet Count: Automated cell counter
- Collection
- Separate serum or plasma from cells within 45 minutes of collection; invert EDTA tube immediately 8 to 10 times once tube is filled at time of collection.
- Reference notes
- 0 – 1.29: low risk for advanced liver fibrosis 1.30 – 2.67: Indeterminate risk for advanced liver fibrosis >2.67: high risk for advanced fibrosis and for developing of other liver-related events
FIB-4 With Reflex to Enhanced Liver Fibrosis (ELF)™ 402175
4 analytes · Serum · Fasting not stated · Turnaround 3 - 6 days
Labcorp catalog pageMethod and collection
- Method
- AST and ALT: kinetic Platelet Count: automated cell counter ELF Reflex if performed: The ELF™ test consists of three fully automated, two-site sandwich immunoassays using direct chemiluminometric technology. The component assays use two monoclonal mouse antibodies: The first antibody is an acridinium ester-labeled antibody. The second antibody is a biotin-labeled antibody. The solid phase contains streptavidin-coated paramagnetic particles. The ELF™ score is derived from an algorithm that combines PIIINP, TIMP-1, and HA. ELF™ is a trademark of Siemens Healthcare Diagnostics.
- Collection
- Serum : Separate from cells within 45 minutes of collection. Whole blood : Invert EDTA tube immediately 8 to 10 times once tube is filled at the time of collection.
FIB-4 With Reflex to NASH FibroSure® Plus 402146
4 analytes · Serum · Fasting not stated · Turnaround Within 1 day
Labcorp catalog pageMethod and collection
- Method
- See individual test components.
- Preparation
- Patient should be fasting for at least eight hours.
- Collection
- Serum : Separate from cells within 45 minutes of collection. Whole blood : Invert EDTA tube immediately 8 to 10 times once tube is filled at the time of collection.
Drug-Induced Liver Injury Profile 010045
6 analytes · Serum · Fasting not stated · Turnaround Within 1 day
Labcorp catalog pageMethod and collection
- Method
- See individual tests.
- Collection
- Serum or plasma: Separate serum or plasma from cells within 45 minutes of collection. PT with INR blood: Blood should be collected in a blue-top tube containing 3.2% buffered sodium citrate. Evacuated collection tubes must be filled to completion to ensure a proper blood-to-anticoagulant ratio. The sample should be mixed immediately by gentle inversion at least six times to ensure adequate mixing of the anticoagulant with the blood. A discard tube is not required prior to collection of coagulation samples unless the sample is collected using a winged (butterfly) collection system. With a winged blood collection set a discard tube should be drawn first to account for the dead space of the tubing and prevent under-filling of the evacuated tube. When noncitrate tubes are collected for other tests, collect sterile and nonadditive (red-top) tubes prior to citrate (blue-top) tubes. Any tube containing an alternative anticoagulant should be collected after the blue-top tube. Gel-barrier tubes and serum tubes with clot initiators should also be collected after the citrate tubes. Print and use the Volume Guide for Coagulation Testing to ensure proper draw volume.
Quest Diagnostics 19 tests
Single-analyte tests
Alanine Aminotransferase (ALT) 823
Serum · Fasting not stated · Turnaround Set up: Mon-Sat; Report available: 3 days
Quest Diagnostics catalog pageMethod and collection
- Method
- Spectrophotometry (SP)
- Preparation
- The assay manufacturer, Beckman Coulter, warns that patients treated with sulfasalazine may generate false low results for ALT.
- Reference notes
- Male (U/L) | Female (U/L) <28 days | 3-25 | 3-25 28 days-11 months | 4-35 | 3-30 1-3 years | 5-30 | 5-30 4-12 years | 8-30 | 8-24 13-15 years | 7-32 | 6-19 16-19 years | 8-46 | 5-32 ≥20 years | 9-46 | 6-29
Panels that include this biomarker
FIB-4 Index Panel with Reflex to Enhanced Liver Fibrosis (ELF) Score 12734
4 analytes · Serum · Fasting not stated
Quest Diagnostics catalog pageMethod and collection
- Method
- Electronic Cell Sizing/Counting/Cytometry/Microscopy • Spectrophotometry (SP)
- Reference notes
- See Laboratory Report
Hepatitis C-Infected Patient, Treatment Panel 91706
4 analytes · Serum · Fasting not stated
Quest Diagnostics catalog pageMethod and collection
- Method
- See individual tests
- Collection
- Whole blood: 1 full EDTA (lavender-top) tube. Submit at room temperature. Serum: 1 spun serum separator tube (SST). Submit at room temperature. Plasma: Collect 2 EDTA (lavender-top) tubes. Spin and pour off into transport tubes. Submit refrigerated. Do not freeze whole blood or any samples stored in primary tube. Freshly drawn specimens (whole blood) may be stored at 2-25° C for up to 24 hours prior to centrifugation. Separate plasma from cells within 24 hours of collection by centrifugation. Follow manufacturer's instructions for collection tube handling.
- Reference notes
- See individual tests
Liver Fibrosis, Fibrosis-4 (FIB-4) Index Panel 30555
4 analytes · Serum · Fasting not stated
Quest Diagnostics catalog pageMethod and collection
- Method
- Spectrophotometry (SP) • Electronic Sizing and Counting/Cytometry/Microscopy
- Collection
- Note: If drawn with lead testing, EDTA (tan-top) is required
- Reference notes
- See Laboratory Report
Hepatic Function Panel without Total Protein 34391
7 analytes · Serum · Fasting not stated
Quest Diagnostics catalog pageMethod and collection
- Method
- See individual tests
NAFLD Fibrosis Score 91979
7 analytes · Serum · Fasting not stated
Quest Diagnostics catalog pageMethod and collection
- Method
- Spectrophotometry (SP) • Electronic Sizing and Counting/Cytometry/Microscopy
- Preparation
- Fasting preferred. Fasting is defined as no consumption of food or beverage other than water for at least 8 hours before testing.
- Collection
- For risk calculations to be performed, the following patient-specific information must be provided at the time of order: Age: Years Gender: M (for male) or F (for female) Height Feet: Feet Height Inches: Inches Weight: lbs. Diabetes Status: Y (for yes) or N (for no)
- Reference notes
- See Laboratory Report
0 of 5 tests selected
Pick one moreGoals and conditions
We link ALT to these goals and conditions from named guidelines and studies.
Energy and fatigueGoal, primary marker
NICE lists liver function among the tests to exclude other diagnoses when ME/CFS is suspected.
Liver healthGoal, primary marker
The ACG guideline names ALT among the most commonly ordered liver chemistries.
Hereditary hemochromatosisCondition, ICD-10 E83.110, companion marker
AASLD recommends liver biopsy when liver enzymes such as ALT are raised.
Metabolic dysfunction-associated steatotic liver disease (MASLD)Condition, ICD-10 K76.0, primary marker
AASLD uses ALT with AST, age and platelets to calculate the FIB-4 fibrosis score.
Sources
24 tests: codes, specimens, methods, preparation and reference intervals.
Quest Diagnostics test catalog
19 tests: codes, specimens, methods, preparation and reference intervals.
Clinical guideline: Metabolic dysfunction-associated steatotic liver disease (MASLD) (primary)
Clinical guideline: Liver health (primary), Range: ACG 2017 true healthy upper limit, men, Range: ACG 2017 true healthy upper limit, women
Clinical guideline: Hereditary hemochromatosis (companion)
Clinical guideline: Energy and fatigue (primary)
Quest Diagnostics Test Directory, Alanine Aminotransferase (ALT) (823), 2025
Laboratory catalog: Range: Quest, men 20 and older, Range: Quest, women 20 and older
MedlinePlus, National Library of Medicine
The description at the top of this page.
Regenstrief Institute codes that identify the same result across labs.
Search ClinicalTrials.gov for ALT
Registered studies that measure ALT, on the U.S. National Library of Medicine registry.
Verify these ranges and sources
We compile this page from named laboratory catalogs, guidelines and studies. Labs calculate reference intervals from the people they test, for one assay method and one population group, so an interval describes that population rather than an optimal target.
Interpret your own results with a licensed clinician, or track your lab history and health goals in Aumnivida.
Spotted an error? Email hello@biomarkerlens.com with the page URL and the primary source that corrects the entry.